Learn More
Medchemexpress LLC Ensitrelvir fumarate | 2757470-18-9 | 99.99% | C26H21ClF3N9O6 | 1 ML

Supplier: Medchemexpress LLC HY143216A10MM/1ML
Ensitrelvir (S-217622) fumarate is the first orally active, non-covalent, non-peptidic SARS-CoV-2 3CL protease inhibitor. It demonstrates high potency with an IC50 of 13 nM and is intended for research use only. The compound has shown significant antiviral activity in vitro against various SARS-CoV-2 variants.
- First orally active, non-covalent, non-peptidic SARS-CoV-2 3CL protease inhibitor.
- Exhibits an IC50 of 13 nM, indicating high potency.
- Effective against wild-type SARS-CoV-2 and Alpha, Beta, Gamma, and Delta variants with EC50 values of approximately 0.4 μM.
- Also active against SARS-CoV and MERS-CoV, with EC50 values of 0.21 and 1.4 μM, respectively.
- Dose-dependently inhibits intrapulmonary replication of SARS-CoV-2 in mice.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.